Substances & reference · openFDA

Historical FDA documents

FDA press releases and papers from the agency's history, as full text. 8,858 records; openFDA updated it 2026-10-02. About this dataset

Newest records

  • For Immediate Release: Jan. 23, 2014

    FDA NEWS RELEASE For Immediate Release: Jan. 23, 2014 FDA prohibits Ranbaxy’s Toansa, India facility from producing and distributing drugs for the U.S. market Another Ranbaxy facility added to existing consent decree Th…

    Press release2 pages
  • For Immediate Release - December 23, 2014

    FDA News Release For Immediate Release - December 23, 2014 FDA approves weight-management drug Saxenda Espafiol The U.S. Food and Drug Administration today approved Saxenda (liraglutide [rDNA origin] injection) as a trea…

    Press release3 pages
  • For Immediate Release - June 6, 2014

    FDA News Release For Immediate Release - June 6, 2014 FDA approves the first antihemophilic factor, Fc fusion protein for patients with Hemophilia A The U.S. Food and Drug Administration today approved Eloctate, Antihem…

    Press release1 pages
  • For Immediate Release - December 16, 2014

    For Immediate Release - December 16, 2014 FDA announces Pharmacy Compounding Advisory Committee members The U.S. Food and Drug Administration today announced the membership of the Pharmacy Compounding Advisory Committee…

    Press release1 pages
  • For Immediate Release - May 29, 2014

    FDA News Release For Immediate Release - May 29, 2014 Espafiol FDA to require warnings on sunlamp products Today, the U.S. Food and Drug Administration issued a final order reclassifying sunlamp products and ultraviolet…

    Press release2 pages
  • News Release For Immediate Release - September 19, 2014

    News Release For Immediate Release - September 19, 2014 FDA releases updated proposals to improve food safety and help prevent foodborne illness in response to public comments _P_ES 350' fiEFPEI Fla-151$ ElllW) Based on…

    Press release2 pages
  • For Immediate Release - September 16, 2014

    FDA News Release For Immediate Release - September 16, 2014 FDA approves Movantik for opioid-induced constipation The U.S. Food and Drug Administration today approved Movantik (naloxegol), an oral treatment for opioid-i…

    Press release2 pages
  • For Immediate Release: Jan. 17, 2014

    FDA STATEM ENT For Immediate Release: Jan. 17, 2014 FDA Commissioner Margaret A. Hamburg's Statement on the 50th Anniversary Surgeon General's Report on Smoking and Health A vision for a comprehensive tobacco control po…

    Press release2 pages
  • For Immediate ReleaseMay 20, 2014

    FDA News Release For Immediate ReleaseMay 20, 2014 FDA approves Entyvio to treat ulcerative colitis and Crohn's disease ReleaseThe U.S. Food and Drug Administration today approved Entyvio (vedolizumab) injection to trea…

    Press release2 pages
  • For Immediate Release: Feb. 12, 2014

    FDA NEWS RELEASE For Immediate Release: Feb. 12, 2014 FDA approves lmbruvica to treat chronic Iymphocytic leukemia The U.S. Food and Drug Administration today expanded the approved use of lmbruvica (ibrutinib) for chron…

    Press release2 pages
  • For Immediate Release - December 4, 2014

    FDA News Release For Immediate Release - December 4, 2014 California seafood company to halt production until FDA documents correction of unsanitary practices Neptune Manufacturing, Inc. must take steps to safely produc…

    Press release2 pages
  • For Immediate Release: April 3, 2014

    FDA NEWS RELEASE For Immediate Release: April 3, 2014 Espafiol FDA allows marketing for first-of-kind dressing to control bleeding from certain battlefield wounds Today, the U.S. Food and Drug Administration allowed mark…

    Press release2 pages
  • For Immediate Release: Feb. 3, 2014

    FDA NEWS RELEASE For Immediate Release: Feb. 3, 2014 FDA approves pediatric use of Dexcom's G4 Platinum continuous glucose monitoring system The U.S. Food and Drug Administration today approved the expanded use of the D…

    Press release2 pages
  • For Immediate Release - December 12, 2014

    FDA News Release For Immediate Release - December 12, 2014 RZM Food Factory to cease operations for repeated food safety violations William H. Oshiro, owner of RZM Food Factory, has agreed to stop processing and distrib…

    Press release2 pages
  • For Immediate Release - December 19, 2014

    FDA News Release For Immediate Release - December 19, 2014 FDA approves pathogen reduction system to treat platelets The U.S. Food and Drug Administration yesterday approved the Intercept Blood System for platelets, the…

    Press release2 pages
  • FDA NEWS RELEASE For Immediate Release: April 29, 2014

    FDA NEWS RELEASE For Immediate Release: April 29, 2014 United States enters consent decree with New York cheese producer due to Listeria contamination Company required to complete significant corrective action to control…

    Press release2 pages
  • For Immediate Release: April 22, 2014

    FDA NEWS RELEASE For Immediate Release: April 22, 2014 FDA proposes new expedited access program for medical devices that address unmet medical needs Agency also clarifies policy on when manufacturers can collect data a…

    Press release2 pages
  • For Immediate Release - July 31, 2014

    FDA News Release For Immediate Release - July 31, 2014 FDA approves Striverdi Respimat to treat chronic obstructive pulmonary disease Today, the U.S. Food and Drug Administration approved Striverdi Respimat (olodaterol)…

    Press release2 pages
  • For Immediate Release - August 14, 2014

    FDA Statement For Immediate Release - August 14, 2014 FDA warns consumers about fraudulent Ebola treatment products Espafiol Francais The U.S. Food and Drug Administration is advising consumers to be aware of products so…

    Press release2 pages
  • For Immediate Release - September 4, 2014

    FDA News Release For Immediate Release - September 4, 2014 FDA approves Keytruda for advanced melanoma First PD-1 blocking drug to receive agency approval Espafiol The U.S. Food and Drug Administration today granted acce…

    Press release2 pages
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.